ATE269313T1 - Tryptase-inhibitoren - Google Patents

Tryptase-inhibitoren

Info

Publication number
ATE269313T1
ATE269313T1 AT00985174T AT00985174T ATE269313T1 AT E269313 T1 ATE269313 T1 AT E269313T1 AT 00985174 T AT00985174 T AT 00985174T AT 00985174 T AT00985174 T AT 00985174T AT E269313 T1 ATE269313 T1 AT E269313T1
Authority
AT
Austria
Prior art keywords
tryptase inhibitors
inhibitors
tryptase
compounds
formula
Prior art date
Application number
AT00985174T
Other languages
English (en)
Inventor
Thomas Baer
Josef Stadlwieser
Wolf-Ruediger Ulrich
Andreas Dominik
Daniela Bundschuh
Karl Zech
Christian Sommerhoff
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE269313T1 publication Critical patent/ATE269313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00985174T 1999-12-20 2000-12-16 Tryptase-inhibitoren ATE269313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125384 1999-12-20
PCT/EP2000/012838 WO2001046168A1 (en) 1999-12-20 2000-12-16 Tryptase inhibitors

Publications (1)

Publication Number Publication Date
ATE269313T1 true ATE269313T1 (de) 2004-07-15

Family

ID=8239661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985174T ATE269313T1 (de) 1999-12-20 2000-12-16 Tryptase-inhibitoren

Country Status (13)

Country Link
US (1) US7015325B2 (de)
EP (1) EP1244643B1 (de)
JP (1) JP2003518109A (de)
AT (1) ATE269313T1 (de)
AU (1) AU783217B2 (de)
CA (1) CA2392121A1 (de)
DE (1) DE60011677T2 (de)
DK (1) DK1244643T3 (de)
ES (1) ES2222259T3 (de)
PT (1) PT1244643E (de)
SI (1) SI1244643T1 (de)
TR (1) TR200402322T4 (de)
WO (1) WO2001046168A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1358182T3 (da) 2001-01-31 2004-12-20 Altana Pharma Ag Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
ES2287268T3 (es) 2001-02-21 2007-12-16 Nycomed Gmbh Inhibidores de triptasa.
EP1368317B1 (de) 2001-02-21 2006-12-27 Altana Pharma AG Tryptaseinhibitoren
JP2004525926A (ja) * 2001-03-15 2004-08-26 アルタナ　ファルマ　アクチエンゲゼルシャフト トリプターゼ阻害剤
WO2002074732A2 (en) * 2001-03-15 2002-09-26 Altana Pharma Ag Tryptase-inhibitors
WO2002102771A1 (en) 2001-06-19 2002-12-27 Altana Pharma Ag Tryptase inhibitors
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2018183654A1 (en) * 2017-03-29 2018-10-04 Minerva Biotechnologies Corporation Agents for differentiating stem cells and treating cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999946A (en) * 1976-02-23 1976-12-28 Allied Chemical Corporation Time-temperature history indicators
US4228126A (en) * 1977-11-25 1980-10-14 Allied Chemical Corporation Diacetylene time-temperature indicators
WO1995032945A1 (en) * 1994-06-01 1995-12-07 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
WO1996009297A1 (en) * 1994-09-23 1996-03-28 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell inflammatory condition
HUP0003267A3 (en) * 1996-07-30 2002-02-28 Arris Pharmaceutical Corp San Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them
US6221914B1 (en) * 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
JP2002502845A (ja) 1998-02-06 2002-01-29 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ トリプターゼ阻害物質
ATE282607T1 (de) 1998-02-06 2004-12-15 Max Planck Gesellschaft Tryptase-inhibitoren
WO2000014097A2 (de) 1998-09-04 2000-03-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue pyranosen
SI1208089T1 (en) 1999-08-10 2005-04-30 Altana Pharma Ag Diazocin-dione derivatives and their use as tryptase inhibitors
WO2001019809A1 (en) 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors

Also Published As

Publication number Publication date
ES2222259T3 (es) 2005-02-01
DE60011677D1 (en) 2004-07-22
DK1244643T3 (da) 2004-10-18
US7015325B2 (en) 2006-03-21
CA2392121A1 (en) 2001-06-28
AU2166901A (en) 2001-07-03
PT1244643E (pt) 2004-10-29
TR200402322T4 (tr) 2004-12-21
AU783217B2 (en) 2005-10-06
SI1244643T1 (en) 2004-12-31
DE60011677T2 (de) 2005-07-14
JP2003518109A (ja) 2003-06-03
WO2001046168A1 (en) 2001-06-28
EP1244643A1 (de) 2002-10-02
EP1244643B1 (de) 2004-06-16
US20030083344A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
ES2186874T3 (es) Analogos de m-amidinofenilo como inhibidores del factor xa.
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
TR200100805T2 (tr) Tetrahidropiridoeterler
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
AU2001264065A1 (en) Serine protease inhibitors
AU2001264081A1 (en) Serine protease inhibitors
BR0007922A (pt) Compostos calcilìticos
DK1244643T3 (da) Tryptaseinhibitorer
ATE287403T1 (de) 6-phenylbenzonaphthyidine
DK1204659T3 (da) Serotonerge benzofuraner
DK1244614T3 (da) Tryptase-inhibitorer
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
DE60216920D1 (en) Tryptase-inhibitoren
ATE364037T1 (de) Tryptasehemmer
ATE491709T1 (de) Pyrrolidinohydrochinazoline
ATE328883T1 (de) Imidazopyridin-8-one
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
ATE349427T1 (de) Tryptaseinhibitoren
AU758194C (en) Novel benzimidazoles and benzoxazoles
SG145572A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1244643

Country of ref document: EP

REN Ceased due to non-payment of the annual fee